Clinical Trials Logo

Abortion, Spontaneous clinical trials

View clinical trials related to Abortion, Spontaneous.

Filter by:

NCT ID: NCT02710006 Completed - Infertility, Clinical Trials

Automatic Volume Calculations During Three-dimensional Sonohysterography.

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this trial is to evaluate the feasibility and reliability of automatic volume calculation of uterine cavity in women with reproductive failures. 3D volumes of uterus and uterine cavity will be acquired during three-dimensional ultrasonography and sonohysterography. After that independent observers will measure offline the uterine cavity volume using automatic volume calculation using SonoAVC general software, and VOCAL software.

NCT ID: NCT02706470 Not yet recruiting - Clinical trials for Miscarriage, Recurrent

Use of Cyclosporin A for the Treatment of Recurrent Miscarriage

Start date: May 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether Cyclosporin A (CsA) - an immunosuppressant drug - in early pregnancy will reduce the risk of miscarriage in women who had a history of unexplained recurrent miscarriages, as compared with that treated with Dydrogesterone-an active comparator. The hypothesis is based on the evidence found in vitro and in vivo experiments that CsA can induce maternal-fetal tolerance so that it may reduce the risk of miscarriage.

NCT ID: NCT02694367 Completed - Clinical trials for Recurrent Miscarriage

Expression of EPK in Recurrent Miscarriage

EPK-RM
Start date: January 2015
Phase: N/A
Study type: Observational

The present study is based on hypotheses that some as yet unknown genetic factors may result in recurrent miscarriage (RM). Consequently, the main aim of this study was to gain new information about the underlying genetic causes of RM in the Egyptian population and to investigate the expression of ERK and p-ERK protein in human placenta and their corresponding tissue, to assess the significance of MAPK signal pathway in progression of recurrent miscarriage and PI3K-Akt Pathway.

NCT ID: NCT02690129 Recruiting - Clinical trials for Threatened Miscarriage

Vaginal Progesterone for Treatment of Threatened Miscarriage

VPM
Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the efficacy of vaginal micronized progesterone in the treatment of threatened miscarriage. All eligible pregnant women will be randomized to either receive vaginal progesterone or no treatment.Evaluation will be two weeks after intervention, then every 4 weeks up to 28 weeks gestation or termination of pregnancy.

NCT ID: NCT02686840 Completed - Missed Abortion Clinical Trials

Sublingual Versus Vaginal Misoprostol In Medical Treatment of First Trimestric Missed Miscarriage

Start date: January 2016
Phase: Phase 3
Study type: Interventional

The aim of this work is to compare the effectiveness of vaginal versus sub-lingual misoprostol for medical treatment of first trimester missed miscarriage.

NCT ID: NCT02681627 Completed - Clinical trials for Recurrent Miscarriage

Sim (Scratch in Miscarriage) Study

SiM
Start date: November 30, 2015
Phase: N/A
Study type: Interventional

There is increasing amount of evidence which suggests that miscarriage is related to a primary endometrial problem. Recent cochrane meta-analysis (March 2015) has proven that endometrial scratch improves live birth in women who underwent IVF. The aim of the study is to find out if scratch of the endometrium prevents recurrent miscarriage.

NCT ID: NCT02657200 Completed - Clinical trials for Spontaneous Abortion

Knowledge, Attitude and Practices of Flemish Midwifes Regarding Spontaneous Abortion

KAP-abortion
Start date: September 2015
Phase: N/A
Study type: Interventional

KAP-study in Flemish midwives with intramural employment

NCT ID: NCT02633878 Recruiting - Clinical trials for Threatened Miscarriage

Chinese Herbal Medicine and Micronized Progesterone for Live Births in Threatened Miscarriage

Start date: September 1, 2017
Phase: Phase 2
Study type: Interventional

Threatened miscarriage is manifested by vaginal bleeding, with or without abdominal pain, while the cervix is closed and the fetus is viable and inside the uterine cavity. Threatened miscarriage is a common complication of pregnancy occurring in 20% of all clinically recognized pregnancies and about half of these will eventually result in pregnancy loss. The goal of this double-bind, randomized and double dummy controlled trial is to determine which of the two oral medications, CHM or micronized progesterone, and will mostly likely result in live birth in women with threatened miscarriage. We will evaluate the efficacy and safety of CHM and micronized progesterone for treating threatened miscarriage in this trial. Our primary outcome of this trial is a live birth. We hypothesize that: 1. treatment with CHM plus micronized progesterone placebo or micronized progesterone plus CHM placebo or CHM plus Micronized progesterone is more likely to result in live birth than the control arm which will be CHM placebo plus micronized progesterone placebo; 2. CHM plus micronized progesterone placebo and micronized progesterone plus CHM placebo will have similar treatment effects.

NCT ID: NCT02633475 Recruiting - Clinical trials for Abortion, Spontaneous

Interleukin-10 Promoter-1082A/G Polymorphism and Idiopathic Recurrent Miscarriage Risk

Start date: August 2015
Phase: N/A
Study type: Observational

This study aimed to assess the correlation between the interleukin-10 (IL-10)-1082A/G polymorphism and idiopathic recurrent miscarriage (IRM) of Chinese Han. A total of 100 women with IRM and 100 control women with a successful pregnancy will be included in this study. Then genotyping will be performed.

NCT ID: NCT02572154 Completed - Clinical trials for RECURRENT PREGNANCY LOSS

Sperm DNA Fragmentation in Recurrent Pregnancy Loss

PARTHOM
Start date: September 2012
Phase: N/A
Study type: Interventional

In human, 2% of couples experimented Recurrent pregnancy loss (RPL). Currently, while etiological investigations were performed, 40 to 50 % of RPL were unexplained. In animals' studies, several studies have underlined the importance of sperm quality for a normal embryo development. In human, epidemiological studies have demonstrated that several male risk factors have effects on development (male mediated development toxicology). However, few studies have explored sperm DNA fragmentation on embryo development but after in vitro fertilization. In natural pregnancy only rare studies have been performed but with different populations definitions and different methods of sperm exploration. In this context sperm DNA fragmentation exploration appears justified. The present study purpose to conduct a case - control study in order to research paternal role in RPL.